Futura Medical (FUM) RNS Announcements

Add to Alert list
Date Time Source Announcement
19 Jun 2023 10:25 AM
RNS
Correction - TR-1: Notification of major holdings
16 Jun 2023 04:05 PM
RNS
TR-1: Notification of major holdings
12 Jun 2023 08:23 AM
RNS
Exercise of Warrants
12 Jun 2023 07:00 AM
RNS
MED3000 Granted US FDA Approval for OTC Sale
08 Jun 2023 07:00 AM
RNS
Futura Medical Announces Investor Seminar
31 May 2023 07:00 AM
RNS
Block Listing Six Monthly Return
26 May 2023 07:00 AM
RNS
Notice of AGM and availability of Annual Report
24 Apr 2023 07:00 AM
RNS
TR-1: Notification of major holdings
24 Apr 2023 07:00 AM
RNS
TR-1: Notification of major holdings
18 Apr 2023 07:00 AM
RNS
MED3000, Eroxon® UK Launch
06 Apr 2023 11:03 AM
RNS
Directors' / PDMR Dealing and Grant of Options
05 Apr 2023 07:00 AM
RNS
Full Year Results ended 31 December 2022
29 Mar 2023 07:00 AM
RNS
Update on MED3000 regulatory approval in the US
27 Mar 2023 05:24 PM
RNS
Notice of Preliminary Results 2022
14 Mar 2023 08:33 AM
RNS
MED3000 commercial and US regulatory update
15 Feb 2023 07:00 AM
RNS
MED3000 FM71 Presentation at ESSM Congress 2023
01 Feb 2023 01:26 PM
RNS
Block Listing Applications to AIM
26 Jan 2023 07:00 AM
RNS
Pre-launch of MED3000 ahead of H1 2023 launch
12 Jan 2023 11:09 AM
RNS
Futura Remuneration, Options & Total Voting Rights
15 Dec 2022 03:01 PM
RNS
TR-1: Notification of major holdings
13 Dec 2022 01:08 PM
EQS
Futura Medical 'on track' for launch in H1 2023
13 Dec 2022 07:00 AM
RNS
Futura Medical announce milestone year for MED3000
30 Nov 2022 07:00 AM
RNS
Futura Block Listing Six Monthly Return
30 Nov 2022 07:00 AM
RNS
Total Voting Rights
21 Oct 2022 04:40 PM
RNS
Second Price Monitoring Extn
21 Oct 2022 04:35 PM
RNS
Price Monitoring Extension
12 Oct 2022 12:25 PM
RNS
TR-1: Notification of major holdings
04 Oct 2022 05:31 PM
RNS
Total Voting Rights
03 Oct 2022 07:00 AM
RNS
Application to the US FDA for MED3000
16 Sep 2022 09:57 AM
RNS
PDMR Dealing and Total Voting Rights
13 Sep 2022 07:00 AM
RNS
Futura Medical Interim Results 2022
01 Sep 2022 07:00 AM
RNS
Notice of Interim Results
31 Aug 2022 07:00 AM
RNS
Highly positive FM71 Phase 3 Study Results
12 Jul 2022 04:41 PM
RNS
Second Price Monitoring Extn
12 Jul 2022 04:35 PM
RNS
Price Monitoring Extension
28 Jun 2022 03:58 PM
RNS
Futura Medical AGM Results
28 Jun 2022 07:00 AM
RNS
Futura Medical AGM Statement
07 Jun 2022 01:33 PM
RNS
TR-1: Notification of major holdings
01 Jun 2022 07:00 AM
RNS
Notice of AGM and Availability of Annual Report
31 May 2022 07:00 AM
RNS
Block Listing Six Monthly Return
24 May 2022 11:40 AM
RNS
TR-1: Notification of major holdings
23 May 2022 10:35 AM
RNS
Agreement with Cooper Consumer Health - Correction
23 May 2022 07:00 AM
RNS
MED3000 Collaboration in EEA, UK & Switzerland
17 May 2022 03:56 PM
RNS
TR-1: Notification of major holdings
16 May 2022 02:51 PM
RNS
TR-1: Notification of major holdings
13 May 2022 12:12 PM
RNS
TR-1: Notification of major holdings
06 May 2022 04:41 PM
RNS
Second Price Monitoring Extn
06 May 2022 04:35 PM
RNS
Price Monitoring Extension
26 Apr 2022 07:00 AM
RNS
Full Year Results 2021
14 Apr 2022 03:54 PM
RNS
Futura Medical Notice of Preliminary Results 2021

Futura Medical is the developer of innovative sexual health products, including lead product Eroxon®. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

FUM share price listed on AIM in 2003.

UK 100